在IBD中肠道微生物群调节:从旧范式到革命性的工具
Marco Murgiano1, Bianca Bartocci1, Pierluigi Puca1,2
1Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
微生物调制为炎症性肠病 (IBD) 提供了新的治疗策略. 新兴的生物疗法显示出个性化IBD管理的希望,改善患者的生活质量.
科学领域:
- 胃肠道学和微生物学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 炎症性肠道疾病 (IBD),包括性结肠炎和克罗恩病,是慢性疾病.
- 肠道微生物群在IBD病原发生中的作用是显著的,但尚未完全理解.
- 目前的IBD治疗方法有局限性,这推动了对新疗法的研究.
研究的目的:
- 审查微生物调制作为IBD的治疗策略.
- 突出目前针对微生物群的治疗方法和新兴的生物疗法.
- 探索这些创新的IBD管理方法的临床潜力.
主要方法:
- 审查有关IBD和肠道微生物群的现有文献.
- 对当前针对微生物群的治疗方法 (前生物,益生菌,共生菌,后生物) 的分析.
- 检查正在开发的新型微生物生物疗法 (FMT,下一代益生菌,菌体等). ) 的情况.
主要成果:
- 微生物群调节是一种有前途的IBD辅助疗法,影响生活质量.
- 便微生物群移植 (FMT) 是一种已批准的基于微生物群的治疗方法.
- 一系列先进的微生物生物疗法正在研究IBD.
结论:
- 微生物生物疗法代表了IBD管理的个性化和前沿方法.
- 需要进一步的研究,以了解这些新型疗法的全部临床应用.
- 微生物群调制具有管理肠道炎症疾病的巨大潜力.
更多相关视频
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
What is Monogastric Digestion?
